Document is current

Any future updates will be listed below

Correction: Cost-Effectiveness of Dupilumab and Oral Janus Kinase Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis in Singapore

Crossref DOI link: https://doi.org/10.1007/s41669-024-00516-4

Published Online: 2024-08-02

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark